Loading clinical trials...
Loading clinical trials...
This study aims to evaluate the value of Shexiang Baoxin Pill (MUSKARDIA) in patients with acute myocardial infarction (AMI) through a prospective, multicenter, pragmatic randomized controlled real-wo...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shanghai Hutchison Pharmaceuticals Limited
Collaborators
NCT06939738 · Acute Myocardial Infarction (AMI)
NCT06744322 · Acute Myocardial Infarction (AMI)
NCT06916520 · Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
NCT07293923 · Cardiogenic Shock, Heart Failure, and more
NCT06788275 · Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, and more
Zhongshan Hospital, Fudan University
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions